CERT
Certara, Inc. Common StockstockNASDAQ
certara is a leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes. certara's solutions, which span the drug development and patient care lifecycle, help increase the probability of regulatory and commercial success by using the most scientifically advanced modeling and simulation technologies and regulatory strategies. its clients include hundreds of global biopharmaceutical companies, leading academic institutions and key regulatory agencies. for more information, visit www.certara.com.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 12.13 | 2026-11-10 | -5.61% | -0.544 |
| 1M | 9.37 | 2026-10-16 | +22.14% | -0.506 |
| 3M | 8.00 | 2026-08-17 | +43.06% | 0.124 |
| 6M | 4.56 | 2026-05-18 | +150.99% | 0.155 |
| 1Y | 8.17 | 2025-11-17 | +40.09% | 0.453 |
| 2Y | 9.99 | 2024-11-18 | +14.56% | — |
| 5Y | 36.01 | 2021-11-17 | -68.22% | 1.129 |
Certara, Inc. Common Stock (NASDAQ:CERT) stock price today is $11.45, and today's volume is 198,176. CERT is up 0.483% today. The 30 day average volume is 2.81M. CERT market cap is $1.75B with 152.54M shares outstanding.